Since the publication of Shapiro and colleagues review article on a primary care approach to substance misuse in 2013, patterns of substance use (particularly opioids) has changed so dramatically in the United States that President Trump on October 26, 2017 proclaimed the opioid epidemic a national public health emergency.
On November 13, 2017, the American Heart Association (AHA) and the American College of Cardiology (ACC) jointly announced new clinical practice guidelines for the management of high blood pressure (HBP) in adults.
Parkinson’s disease (PD) treatment is complex and requires the integration of a multi-member healthcare team. However, patients are often challenged with limited access to specialists. In fact, more that 40% of PD patients do not see a neurologist within the first four years of diagnosis.
Twenty-first century technology is now beginning to blend payment with measureable health value management of patient populations, requiring pro-active PHM. More and more, alternative payment models (APMs) are requiring providers to think of PHM beyond their individual patient populations to community-wide consumers of their services; achieving an improved health status across the care continuum.
By now, you have heard of the Medicare reform terms associated with the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA), namely the merit-based incentive payment system (MIPS) and advanced alternative payment models (A-APMs). Beginning in 2019, physicians, physician assistants, nurse practitioners, clinical nurse specialists, and CRNAs paid under a Medicare Physician Fee Schedule (MPFS) will be subject to one of these two new payment methodologies based on measured performance in the preceding two years (2017 for a 2019 payment year).
As we have recently been reminded during a series of natural disasters in the United States, health care providers have the extraordinary opportunity to intervene and save the lives of injured family, friends, neighbors, and strangers.
A Case Study: Shortly after people throughout the United States had an opportunity to witness a total solar eclipse, primary care providers began hearing from patients who had viewed the eclipse without protective equipment and now have concerns about their vision…
Streamed live from Headache Update 2017, join the discussion as faculty present the most up-to-date information being reported in clinical trials for the new calcitonin gene-related peptide (CGRP) inhibitors.